Schedule 13G ownership disclosure

Context Therapeutics, Inc.

Common Stock, par value $0.001 per share · CUSIP: 21077P108

Event date: 2024-12-31

Filing-level shares
0.00
Percent of class
0.00%
  • Opaleye Management Inc.

    Shares: 0.00 · Class: 0.00%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-25-006561
Form type
SCHEDULE 13G/A
Filer
Context Therapeutics Inc.
CIK
CIK 1842952
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub